Mark is an accomplished medical technology executive with demonstrated success transforming industries and driving breakthrough technologies to market leadership. Prior to joining Delphinus, Mark was president and chief executive officer of OptiMedica Corporation, an ophthalmic medical device company. He led the start-up venture through development and growth, successfully completed multiple rounds of financing, and oversaw the company’s acquisition by Abbott Laboratories in 2013. He began his career in the medical technology industry as a sales representative at Greishaber and Company, Inc., where he ultimately became vice president of U.S. sales and marketing and led the company through its acquisition by Alcon. During his tenure at Alcon, he steered the tactical integration of Grieshaber and advanced to Vice President of vitreoretinal sales and global marketing. Mark has a bachelor’s degree in marketing from Auburn University and completed the Harvard Program for Management Development. He is currently on the Dean’s Advisory Board of the Harbert College of Business at Auburn.